Inovio Kicks Off 2nd Stage of Phase 1 Human Trials of Ebola DNA Vaccine; J. Joseph Kim Comments

Inovio Pharmaceuticals has begun to enroll 125 individuals for the second stage of the Phase 1 clinical trial of its Ebola DNA vaccine candidate in an … Full Article http://j.gs/5sTq

Click here to read full article